XRAY DENTSPLY SIRONA Inc.
Dental Equipment & Supplies · Nasdaq · SEC CIK 818479 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-1.4%
TTM net income YoY86.3%
TTM EPS YoY86.1%
Revenue 3-yr CAGR-3.2%
Net income 3-yr CAGR—
Margins
Gross margin50.5%
Operating margin-1.5%
Net margin-3.4%
FCF margin2.9%
EBITDA margin7.9%
Returns
ROE-8.5%
ROA-2.2%
ROIC (approx.)-1.3%
Asset turnover0.66x
Leverage & solvency
Liabilities / assets73.9%
Debt / equity1.62x
Current ratio1.63x
Interest coverage-0.59x
Cash quality & payout
Operating cash flow / net income-2.25x
Accruals ratio-7.2%
Payout ratio—
Capex / revenue4.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $836.00M | $898.00M | $880.00M | $961.00M | $904.00M | $936.00M | $879.00M | $905.00M |
| Cost of revenue | $393.00M | $405.00M | $453.00M | $518.00M | $463.00M | $446.00M | $413.00M | $459.00M |
| Gross profit | $443.00M | $493.00M | $427.00M | $443.00M | $441.00M | $490.00M | $466.00M | $446.00M |
| R&D expense | $42.00M | $45.00M | $44.00M | $40.00M | $37.00M | $37.00M | $36.00M | $42.00M |
| SG&A expense | $363.00M | $364.00M | $351.00M | $383.00M | $355.00M | $342.00M | $358.00M | $401.00M |
| Operating income | $37.00M | $82.00M | -$35.00M | -$139.00M | -$218.00M | -$128.00M | $63.00M | -$509.00M |
| Interest expense | $25.00M | $22.00M | $24.00M | $22.00M | $23.00M | $24.00M | $19.00M | $16.00M |
| Pretax income | $26.00M | $72.00M | -$42.00M | -$147.00M | -$230.00M | -$153.00M | $44.00M | -$523.00M |
| Income tax | $29.00M | $36.00M | -$32.00M | -$2.00M | $198.00M | -$109.00M | $25.00M | -$95.00M |
| Net income | -$2.00M | $37.00M | -$10.00M | -$146.00M | -$427.00M | -$45.00M | $20.00M | -$430.00M |
| EBITDA | $119.00M | $167.00M | $44.00M | -$46.00M | -$126.00M | -$40.00M | $142.00M | -$421.00M |
| EPS (basic) | -0.01 | 0.18 | -0.05 | — | -2.14 | -0.22 | 0.10 | — |
| EPS (diluted) | -0.01 | 0.18 | -0.05 | — | -2.14 | -0.22 | 0.10 | — |
| Dividends declared per share | — | — | — | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 |
| Weighted avg. shares (diluted) | 199.20M | 200.50M | 199.90M | — | 199.50M | 199.30M | 199.80M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $195.00M | $239.00M | $190.00M | $326.00M | $363.00M | $359.00M | $398.00M | $272.00M |
| Inventory | $707.00M | $665.00M | $659.00M | $642.00M | $686.00M | $675.00M | $612.00M | $564.00M |
| Current assets | $1.98B | $1.93B | $1.84B | $2.02B | $2.07B | $1.97B | $1.98B | $1.75B |
| PP&E, net | $845.00M | $845.00M | $858.00M | $861.00M | $841.00M | $840.00M | $791.00M | $766.00M |
| Goodwill | $1.14B | $1.14B | $1.14B | $1.15B | $1.27B | $1.53B | $1.63B | $1.60B |
| Intangibles | $815.00M | $870.00M | $924.00M | $974.00M | $1.06B | $1.13B | $1.21B | $1.21B |
| Total assets | $5.19B | $5.20B | $5.23B | $5.43B | $5.65B | $6.07B | $6.05B | $5.75B |
| Current liabilities | $1.22B | $1.19B | $1.21B | $1.34B | $1.41B | $1.17B | $1.79B | $1.59B |
| Short-term debt | $215.00M | $228.00M | $230.00M | $313.00M | $378.00M | $184.00M | $742.00M | $549.00M |
| Long-term debt | $1.99B | $2.00B | $2.01B | $2.02B | $2.02B | $2.22B | $1.59B | $1.59B |
| Total debt | $2.20B | $2.22B | $2.24B | $2.33B | $2.40B | $2.40B | $2.33B | $2.13B |
| Total liabilities | $3.84B | $3.85B | $3.91B | $4.09B | $4.17B | $4.11B | $4.04B | $3.81B |
| Shareholders' equity | $1.35B | $1.35B | $1.32B | $1.34B | $1.48B | $1.96B | $2.01B | $1.94B |
| Net debt | $2.00B | $1.99B | $2.05B | $2.00B | $2.03B | $2.04B | $1.94B | $1.86B |
| Shares outstanding | 198.20M | 199.20M | 200.30M | 199.60M | 199.50M | 199.30M | 199.30M | 198.80M |
| Cash flow statement | ||||||||
| Operating cash flow | $32.00M | $99.00M | $40.00M | $101.00M | $79.00M | $48.00M | $7.00M | $87.00M |
| Capital expenditure | $32.00M | $44.00M | $52.00M | $41.00M | $39.00M | $32.00M | $19.00M | $51.00M |
| Free cash flow | $0 | $55.00M | -$12.00M | $60.00M | $40.00M | $16.00M | -$12.00M | $36.00M |
| Investing cash flow | -$43.00M | -$39.00M | -$53.00M | -$45.00M | -$36.00M | -$34.00M | -$17.00M | -$57.00M |
| Financing cash flow | -$28.00M | -$11.00M | -$119.00M | -$99.00M | -$36.00M | -$68.00M | $123.00M | -$38.00M |
| Depreciation & amortization | $82.00M | $85.00M | $79.00M | $93.00M | $92.00M | $88.00M | $79.00M | $88.00M |
| Stock-based compensation | $8.00M | $9.00M | $8.00M | $8.00M | $6.00M | $9.00M | $10.00M | $4.00M |
| Dividends paid | $0 | $0 | $32.00M | $32.00M | $32.00M | $32.00M | $32.00M | $31.00M |
| Share buybacks | $13.00M | — | — | $0 | $0 | — | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 74 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.